UCSF Radiopharmaceutical Facility
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 185 Berry Street Suite 350, San Francisco, California (CA) 94107, United States (USA)
- Operations here
- positron emission tomography drug production
- FDA identifiers
- FEI 3005947301 · DUNS 831727388
Recent inspection flagged official action
FDA classified an inspection here as OAI (official action indicated) within the last two years — the strongest public warning signal a facility gets. This plant is listed on labels for 3 drugs. A supply problem here can ripple to all of them.
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- OAIDrug Quality Assurance2025-07-24
- VAIDrug Quality Assurance2020-07-24
- VAIDrug Quality Assurance2015-11-05
Drugs this plant is listed as making
3 distinct drugs across 3 products name this site in their FDA label.
- Fludeoxyglucose F18UCSF Radiopharmaceutical Facility
- Gallium Ga-68 GozetotideUCSF Radiopharmaceutical Facility
- Nh3n13UCSF Radiopharmaceutical Facility
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.